Close

Taysha Gene Therapies (TSHA) Misses Q1 EPS by 24c

May 16, 2022 7:06 AM EDT

Taysha Gene Therapies (NASDAQ: TSHA) reported Q1 EPS of ($1.31), $0.24 worse than the analyst estimate of ($1.07).

For earnings history and earnings-related data on Taysha Gene Therapies (TSHA) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings